network member

Moores Cancer Center at UC San Diego Health

About Network Member

Website: https://health.ucsd.edu/locations/Pages/moores.aspx

https://health.ucsd.edu/locations/Pages/moores.aspx"> https://health.ucsd.edu/locations/Pages/moores.aspx

Currently Enrolling

HCRN-GU20-436

NePtune: A Phase 2 Study of Neoadjuvant PARP Inhibition followed by Radical Prostatectomy in Patients with Unfavorable Intermediate-Risk or High-Risk Prostate Cancer with BRCA1/2 Gene Alterations

Cancer areas:Prostate

Columbia University Irving Medical Center

Memorial Sloan Kettering Cancer Center

Moores Cancer Center at UC San Diego Health

Penn Medicine Abramson Cancer Center

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

See clinicaltrials.gov

Currently Enrolling

HCRN-GU21-517

A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY)

Cancer areas:Prostate

Moores Cancer Center at UC San Diego Health

The University of Chicago Medicine Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

UT Southwestern Harold C. Simmons Comprehensive Cancer Center

See clinicaltrials.gov

Currently Enrolling

HCRN-GU22-587

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)

Cancer areas:Kidney

Beth Israel Deaconess Medical Center

Columbia University Irving Medical Center

Dana-Farber Cancer Institute

Georgetown Lombardi Comprehensive Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

John Theurer Cancer Center at Hackensack Meridian Health

Moores Cancer Center at UC San Diego Health

Penn Medicine Abramson Cancer Center

The Ohio State University

UT Southwestern Harold C. Simmons Comprehensive Cancer Center

Weill Cornell Medicine

Winship Cancer Institute of Emory University

Yale Cancer Center

See clinicaltrials.gov

Currently Enrolling

HCRN-HN23-623

A Phase II, Single Arm, Open Label, Multi-center Trial of Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Previously Untreated Locally Advanced, Resectable, HPV Mediated Oropharynx Cancer

Cancer areas:Head and Neck

Knight Cancer Institute at Oregon Health & Science University

Moores Cancer Center at UC San Diego Health

Providence Cancer Institute

See clinicaltrials.gov